Top 100 scientists can be ranked globally or specific to the following regions including Africa, Asia, Europe, North America, Latin America, Oceania, Arab League, ASEAN, EECA, and BRICS based on total H-index scores without any breakdown by subject areas. Top 100 rankings in the world, in a continent, or a region include standardized subjects areas of Agriculture & Forestry, Arts, Design and Architecture, Business & Management, Economics & Econometrics, Education, Engineering & Technology, History, Philosophy, Theology, Law/Law and Legal Studies, Medical and Health Sciences, Natural Sciences, Social Sciences, Art and Humanities Rankings and Social Sciences and Humanities Rankings BETA VERSION. Subject field ranking in world, region, country and university is beta version since subject field "others" (873,690 scientists profile whose branch cannot be determined, not yet edited or determined) is excluded, so the ranking will change as the others fields are edited. Please note that. Subjects indicated as “ * others ” will not be included in the ranking by regions and subjects.
psychosis
neurodegeneration
bioinformatics
genomics
drug development
Metrics
H-Index
i10 Index
Citation
124
447
86,614
PBPK Models
DDI
CYPs
Metrics
H-Index
i10 Index
Citation
78
176
23,219
Neuroscience & Drug Discovery
Metrics
H-Index
i10 Index
Citation
76
144
25,818
GI cancer
translational research
lung cancer
phase 1 trials
Metrics
H-Index
i10 Index
Citation
74
175
27,347
Drug Discovery
Informatics
Computational Chemistry
Biophysics
Nanotechnology
Metrics
H-Index
i10 Index
Citation
67
208
18,265
Metrics
H-Index
i10 Index
Citation
64
105
13,353
Neurodegeneration
Neuroscience
Metrics
H-Index
i10 Index
Citation
62
135
11,376
Alzheimer's disease
Neurodegeneration
Drug discovery
Metrics
H-Index
i10 Index
Citation
60
83
36,550
Osteoporosis
Migraine
Cardiovascular Disease
Drug Development
Metrics
H-Index
i10 Index
Citation
55
99
15,231
* Rankings
Ranking Based
On Selection: 10
oncology/I-O/autoimmune diseases
drug discovery
kinases
epigenetics
RNA modulation
Metrics
H-Index
i10 Index
Citation
54
112
10,237
* Rankings
Ranking Based
On Selection: 11
Diabetes
endocrinology
fatty liver disease
Metrics
H-Index
i10 Index
Citation
52
76
10,586
* Rankings
Ranking Based
On Selection: 12
Drug Discovery
G-proteins
GPCRs
Receptors
Pharmacology
Metrics
H-Index
i10 Index
Citation
50
81
8,258
* Rankings
Ranking Based
On Selection: 13
Metrics
H-Index
i10 Index
Citation
49
140
10,097
* Rankings
Ranking Based
On Selection: 14
Immuno-Oncology
Metrics
H-Index
i10 Index
Citation
48
216
10,460
* Rankings
Ranking Based
On Selection: 15
process chemistry
organic chemistry. pharmaceutical
green chemistry
catalysis
Metrics
H-Index
i10 Index
Citation
47
150
10,197
* Rankings
Ranking Based
On Selection: 16
Heart disease
inflammation
diabetes
noncoding RNAs
systems biology
Metrics
H-Index
i10 Index
Citation
44
75
7,651
* Rankings
Ranking Based
On Selection: 17
Drug Discovery and Development
Precision Medicine
Digital Health
Genetics
Orphan diseases
Metrics
H-Index
i10 Index
Citation
44
66
10,326
* Rankings
Ranking Based
On Selection: 18
Lipoprotein Metabolism and Atherosclerosis
Metrics
H-Index
i10 Index
Citation
44
75
8,021
* Rankings
Ranking Based
On Selection: 19
Cancer
Metrics
H-Index
i10 Index
Citation
43
65
6,251
* Rankings
Ranking Based
On Selection: 20
Alzheimer's disease
Metrics
H-Index
i10 Index
Citation
42
84
12,220
* Rankings
Ranking Based
On Selection: 21
Metrics
H-Index
i10 Index
Citation
42
88
9,025
* Rankings
Ranking Based
On Selection: 22
psychopharmamcology
Metrics
H-Index
i10 Index
Citation
42
73
7,570
* Rankings
Ranking Based
On Selection: 23
diabetes
cardiovascular diseases
osteoporosis
Metrics
H-Index
i10 Index
Citation
41
88
6,167
* Rankings
Ranking Based
On Selection: 24
Clinical research
patients
methodology
effectiveness
cost-effectiveness
Metrics
H-Index
i10 Index
Citation
41
106
6,908
* Rankings
Ranking Based
On Selection: 25
RNA
Oligonucleotides
Delivery of Novel Modalities
Virology
SARS-CoV-2
Metrics
H-Index
i10 Index
Citation
40
64
13,087
* Rankings
Ranking Based
On Selection: 26
Statistics
Applied statistics in drug discovery
Translational research
Metrics
H-Index
i10 Index
Citation
39
68
8,200
* Rankings
Ranking Based
On Selection: 27
Clinical Trials
Inflammatory Bowel Disease
Metrics
H-Index
i10 Index
Citation
37
68
5,677
* Rankings
Ranking Based
On Selection: 28
Metrics
H-Index
i10 Index
Citation
36
53
6,248
* Rankings
Ranking Based
On Selection: 29
Health outcomes
pediatrics
epidemiology
Metrics
H-Index
i10 Index
Citation
35
69
7,373
* Rankings
Ranking Based
On Selection: 30
Immunooncology
Myeloid Biology
Angiogenesis
Oncology
Cancer Therapeutics
Metrics
H-Index
i10 Index
Citation
35
57
5,881
* Rankings
Ranking Based
On Selection: 31
Health Outcomes
Real World Evidence
Pain
Metrics
H-Index
i10 Index
Citation
34
53
10,520
* Rankings
Ranking Based
On Selection: 32
structural biology
computational biology
structural bioinformatics
biophysics
Metrics
H-Index
i10 Index
Citation
34
56
6,528
* Rankings
Ranking Based
On Selection: 33
Diabetes
Metrics
H-Index
i10 Index
Citation
33
68
6,269
* Rankings
Ranking Based
On Selection: 34
Statistics
Metrics
H-Index
i10 Index
Citation
33
63
3,398
* Rankings
Ranking Based
On Selection: 35
innate immunity
neuroimmunology
neurodegneration
pathagen/damage associated molecular patterns
host-pathogen interaction
Metrics
H-Index
i10 Index
Citation
32
34
10,757
* Rankings
Ranking Based
On Selection: 36
Computational chemistry
molecular modeling
biophysics
Metrics
H-Index
i10 Index
Citation
32
74
4,193
* Rankings
Ranking Based
On Selection: 37
Metrics
H-Index
i10 Index
Citation
32
50
6,493
* Rankings
Ranking Based
On Selection: 38
Quality of life research
Patient-reported outcomes
Health economics
Cancer
Metrics
H-Index
i10 Index
Citation
31
53
3,322
* Rankings
Ranking Based
On Selection: 39
Biotechnology
Drug Discovery
Chemical Biology
Glycobiology
Metrics
H-Index
i10 Index
Citation
31
46
2,480
* Rankings
Ranking Based
On Selection: 40
osteopetrosis
psoriatic arthritis
rheumatoid arthritis
muscle
osteoarthrtis
Metrics
H-Index
i10 Index
Citation
31
41
4,229
* Rankings
Ranking Based
On Selection: 41
Metrics
H-Index
i10 Index
Citation
31
53
4,518
* Rankings
Ranking Based
On Selection: 42
Statistics
clinical trials
health outcomes research
Bayesian methods
Metrics
H-Index
i10 Index
Citation
31
41
4,710
* Rankings
Ranking Based
On Selection: 43
cancer cure and business
power of brain
VR and AI
extreme sports psychology and sociology
Metrics
H-Index
i10 Index
Citation
31
47
5,856
* Rankings
Ranking Based
On Selection: 44
Drug discovery
Metrics
H-Index
i10 Index
Citation
30
50
4,305
* Rankings
Ranking Based
On Selection: 45
Cardiometabolic Endocrinology
GLP-1RA
Obesity
NASH
Metrics
H-Index
i10 Index
Citation
28
37
6,871
* Rankings
Ranking Based
On Selection: 46
Analytical Chemistry
Toxicology
Mass Spectrometry
Chemometrics
Metrics
H-Index
i10 Index
Citation
28
42
2,483
* Rankings
Ranking Based
On Selection: 47
Epidemiology
Metrics
H-Index
i10 Index
Citation
28
34
3,127
* Rankings
Ranking Based
On Selection: 48
rheumatology
jak inhibitors
COVID
hyperinflammatory states
dermatology
Metrics
H-Index
i10 Index
Citation
27
34
7,713
* Rankings
Ranking Based
On Selection: 49
clinical Natural Language Processing
information extraction
predictive modeling
Metrics
H-Index
i10 Index
Citation
27
38
3,297
* Rankings
Ranking Based
On Selection: 50
Oncology
Genomics
Tailored Therapeutics
Metrics
H-Index
i10 Index
Citation
27
35
19,763
* Rankings
Ranking Based
On Selection: 51
Diabetes Obesity and Complications
Metrics
H-Index
i10 Index
Citation
27
34
4,476
* Rankings
Ranking Based
On Selection: 52
Metrics
H-Index
i10 Index
Citation
27
40
15,227
* Rankings
Ranking Based
On Selection: 53
Oncology
Metrics
H-Index
i10 Index
Citation
27
38
10,427
* Rankings
Ranking Based
On Selection: 54
Insulin receptor
diabetes
systems biology
NCAM
FGFR
Metrics
H-Index
i10 Index
Citation
27
36
2,688
* Rankings
Ranking Based
On Selection: 55
Bayesian Statistics
Clinical Trials
Survival Analysis
Metrics
H-Index
i10 Index
Citation
26
49
3,383
* Rankings
Ranking Based
On Selection: 56
Oncology
Neuroscience
Life Sciences
Metrics
H-Index
i10 Index
Citation
26
32
9,023
* Rankings
Ranking Based
On Selection: 57
Clinical trial design
missing data
generalized linear models
surrogate marker
Metrics
H-Index
i10 Index
Citation
26
41
2,471
* Rankings
Ranking Based
On Selection: 58
Drug Discovery & Development
Metrics
H-Index
i10 Index
Citation
26
44
2,376
* Rankings
Ranking Based
On Selection: 59
Design of Clinical Trials
Statistics
Data Analysis
Modeling
Methods for Observational Studies
Metrics
H-Index
i10 Index
Citation
25
55
2,272
* Rankings
Ranking Based
On Selection: 60
Drug discovery
organic chemistry
continuous flow chemistry
Metrics
H-Index
i10 Index
Citation
25
44
2,273
* Rankings
Ranking Based
On Selection: 61
Multivariate Latent Variable Methods
Optimization
Process Modeling
Advanced Control
Metrics
H-Index
i10 Index
Citation
25
51
2,058
* Rankings
Ranking Based
On Selection: 62
Synchrotron Beamlines
Macromolecular Crystallography
Drug Discovery and Design
Metrics
H-Index
i10 Index
Citation
25
37
3,283
* Rankings
Ranking Based
On Selection: 63
Immunology
Autoimmunity
Translational Science
Translational Medicine
Metrics
H-Index
i10 Index
Citation
25
38
2,154
* Rankings
Ranking Based
On Selection: 64
Metrics
H-Index
i10 Index
Citation
24
33
3,467
* Rankings
Ranking Based
On Selection: 65
Muscle & Metabolism
Metrics
H-Index
i10 Index
Citation
24
25
4,590
* Rankings
Ranking Based
On Selection: 66
Organic Synthesis
Flow Chemistry
Metrics
H-Index
i10 Index
Citation
23
40
2,119
* Rankings
Ranking Based
On Selection: 67
Genetics
Bioinformatics
Data Science and Drug Discovery Informatics
Metrics
H-Index
i10 Index
Citation
23
30
5,280
* Rankings
Ranking Based
On Selection: 68
crystallization
Metrics
H-Index
i10 Index
Citation
22
33
2,020
* Rankings
Ranking Based
On Selection: 69
Imunnology
Metrics
H-Index
i10 Index
Citation
22
31
3,438
* Rankings
Ranking Based
On Selection: 70
Medicinal chemistry
drug discovery
organic chemistry
Metrics
H-Index
i10 Index
Citation
22
27
1,545
* Rankings
Ranking Based
On Selection: 71
Statistics
Oncology Research
Metrics
H-Index
i10 Index
Citation
21
30
2,986
* Rankings
Ranking Based
On Selection: 72
machine learning
drug design
docking
molecular modeling
Metrics
H-Index
i10 Index
Citation
21
33
1,275
* Rankings
Ranking Based
On Selection: 73
PK/PD
clinical pharmacology
asset management
Metrics
H-Index
i10 Index
Citation
21
31
2,283
* Rankings
Ranking Based
On Selection: 74
Biology
Metrics
H-Index
i10 Index
Citation
21
27
2,501
* Rankings
Ranking Based
On Selection: 75
Biotechnology
Biochemistry
Molecular Biology
Biologic Drug Development
Metrics
H-Index
i10 Index
Citation
21
23
2,435
* Rankings
Ranking Based
On Selection: 76
External Innovation and Drug Discovery
Metrics
H-Index
i10 Index
Citation
21
28
1,210
* Rankings
Ranking Based
On Selection: 77
pharmaceutical
Metrics
H-Index
i10 Index
Citation
20
30
1,650
* Rankings
Ranking Based
On Selection: 78
Materials Science and Engineering
Analytical
Formulation
Process
Automation
Metrics
H-Index
i10 Index
Citation
20
25
6,101
* Rankings
Ranking Based
On Selection: 79
Metrics
H-Index
i10 Index
Citation
20
26
2,084
* Rankings
Ranking Based
On Selection: 80
diabetes
Metrics
H-Index
i10 Index
Citation
20
23
5,676
* Rankings
Ranking Based
On Selection: 81
Drug Discovery
Metrics
H-Index
i10 Index
Citation
20
23
1,171
* Rankings
Ranking Based
On Selection: 82
immunity
informatics
Metrics
H-Index
i10 Index
Citation
20
27
2,071
* Rankings
Ranking Based
On Selection: 83
Medicinal Chemsitry
Organic Chemistry
Computational Chemistry
Metrics
H-Index
i10 Index
Citation
20
24
1,396
* Rankings
Ranking Based
On Selection: 84
Chemoinformatics
cheminformatics
computer-aided drug design
data science
machine learning
Metrics
H-Index
i10 Index
Citation
19
30
1,841
* Rankings
Ranking Based
On Selection: 85
Real World Evidence
Health Policy
Methodology
Metrics
H-Index
i10 Index
Citation
19
24
2,662
* Rankings
Ranking Based
On Selection: 86
clinical pharmacology
cardiovascular disease
oncology
informatics
human factors
Metrics
H-Index
i10 Index
Citation
19
23
2,120
* Rankings
Ranking Based
On Selection: 87
Diabetes
Obesity
Metabolic Diseases
Cardiovascular and Diabetic Complications
NASH
Metrics
H-Index
i10 Index
Citation
19
21
2,796
* Rankings
Ranking Based
On Selection: 88
Neuroscience
Imaging
cell biology
pain
Metrics
H-Index
i10 Index
Citation
18
19
4,045
* Rankings
Ranking Based
On Selection: 89
protein expression
protein engineering
cell engineering
vegfr2
Metrics
H-Index
i10 Index
Citation
18
19
2,356
* Rankings
Ranking Based
On Selection: 90
Metrics
H-Index
i10 Index
Citation
18
21
1,396
* Rankings
Ranking Based
On Selection: 91
cancer biology
molecular biology
cell biology
tumor biology
immunology
Metrics
H-Index
i10 Index
Citation
18
19
1,578
* Rankings
Ranking Based
On Selection: 92
Rheumatology
Immunology
Autoimmunity
Clinical Trials
Medical Affairs
Metrics
H-Index
i10 Index
Citation
18
21
1,669
* Rankings
Ranking Based
On Selection: 93
Cheminformatics
Data Science
Analytics
Metrics
H-Index
i10 Index
Citation
18
21
1,564
* Rankings
Ranking Based
On Selection: 94
medicine
biostatistics
diabetes
machine learning
Metrics
H-Index
i10 Index
Citation
17
25
1,409
* Rankings
Ranking Based
On Selection: 95
Cancer Genomics
Metrics
H-Index
i10 Index
Citation
17
19
4,537
* Rankings
Ranking Based
On Selection: 96
neuroscience
Metrics
H-Index
i10 Index
Citation
17
19
1,138
* Rankings
Ranking Based
On Selection: 97
Type 2 diabetes
non-alcoholic fatty liver disease
exercise training
metabolic flexibility
mitochondrial function
Metrics
H-Index
i10 Index
Citation
16
19
1,338
* Rankings
Ranking Based
On Selection: 98
Biostatistics
Clinical Trials
Data Science
Metrics
H-Index
i10 Index
Citation
16
18
1,085
* Rankings
Ranking Based
On Selection: 99
Computational Chemistry
Molecular Dynamics Simulation
Quantum Chemistry
Structure-Based Drug
Metrics
H-Index
i10 Index
Citation
16
20
967
* Rankings
Ranking Based
On Selection: 100
Metrics
H-Index
i10 Index
Citation
16
16
3,604
David A Collier
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
124
447
86,614
psychosis
neurodegeneration
bioinformatics
genomics
drug development
Stephen Hall
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
78
176
23,219
Christian C Felder
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
76
144
25,818
Neuroscience & Drug Discovery
David R Ferry
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
74
175
27,347
Jiye Shi
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
67
208
18,265
Drug Discovery
Informatics
Computational Chemistry
Biophysics
Nanotechnology
Eswar Krishnan
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
64
105
13,353
Michael O'Neill
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
62
135
11,376
Martin Citron
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
60
83
36,550
JH Krege
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
55
99
15,231
Bob Campbell
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
54
112
10,237
oncology/I-O/autoimmune diseases
drug discovery
kinases
epigenetics
RNA modulation
Mark L Hartman
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
52
76
10,586
Diabetes
endocrinology
fatty liver disease
Francis Willard
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
50
81
8,258
Drug Discovery
G-proteins
GPCRs
Receptors
Pharmacology
Jonathan A Lee
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
49
140
10,097
Prachi Sharma
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
48
216
10,460
Tony Zhang
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
47
150
10,197
process chemistry
organic chemistry. pharmaceutical
green chemistry
catalysis
Scot J Matkovich
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
44
75
7,651
Heart disease
inflammation
diabetes
noncoding RNAs
systems biology
Sreekumar Pillai
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
44
66
10,326
Drug Discovery and Development
Precision Medicine
Digital Health
Genetics
Orphan diseases
Giacomo Ruotolo
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
44
75
8,021
Louis F Stancato
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
43
65
6,251
Stéphane Epelbaum
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
42
84
12,220
David H Adams
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
42
88
9,025
Joel Raskin
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
42
73
7,570
Imre Pavo
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
41
88
6,167
José Antonio Sacristán
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
41
106
6,908
Clinical research
patients
methodology
effectiveness
cost-effectiveness
Andrew C Adams
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
40
64
13,087
RNA
Oligonucleotides
Delivery of Novel Modalities
Virology
SARS-CoV-2
Richard E Higgs
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
39
68
8,200
Statistics
Applied statistics in drug discovery
Translational research
Klaus Gottlieb
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
37
68
5,677
James W Perfield Ii
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
36
53
6,248
Joe Johnston
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
35
69
7,373
Health outcomes
pediatrics
epidemiology
Sudhakar Reddy Chintharlapalli
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
35
57
5,881
Immunooncology
Myeloid Biology
Angiogenesis
Oncology
Cancer Therapeutics
Rebecca L Robinson
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
34
53
10,520
J Michael Sauder
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
34
56
6,528
structural biology
computational biology
structural bioinformatics
biophysics
Zvonko Milicevic
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
33
68
6,269
Ilya Lipkovich
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
33
63
3,398
Yaming Wang
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
32
34
10,757
innate immunity
neuroimmunology
neurodegneration
pathagen/damage associated molecular patterns
host-pathogen interaction
Howard Broughton
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
32
74
4,193
Computational chemistry
molecular modeling
biophysics
David Cox
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
32
50
6,493
Nalin Payakacha
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
31
53
3,322
Quality of life research
Patient-reported outcomes
Health economics
Cancer
Henning Stöckmann
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
31
46
2,480
Biotechnology
Drug Discovery
Chemical Biology
Glycobiology
Olivier Benichou
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
31
41
4,229
osteopetrosis
psoriatic arthritis
rheumatoid arthritis
muscle
osteoarthrtis
Robert W Siegel
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
31
53
4,518
Wei Shen
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
31
41
4,710
Statistics
clinical trials
health outcomes research
Bayesian methods
Michal Vieth
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
31
47
5,856
cancer cure and business
power of brain
VR and AI
extreme sports psychology and sociology
Prashant Desai
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
30
50
4,305
Mathijs C Bunck
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
28
37
6,871
Valentina Pirro
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
28
42
2,483
Analytical Chemistry
Toxicology
Mass Spectrometry
Chemometrics
Ying Liu
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
28
34
3,127
Stephanie De Bono
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
27
34
7,713
rheumatology
jak inhibitors
COVID
hyperinflammatory states
dermatology
Min Jiang
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
27
38
3,297
clinical Natural Language Processing
information extraction
predictive modeling
Ricardo Martinez
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
27
35
19,763
Oncology
Genomics
Tailored Therapeutics
Matthew Coghlan
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
27
34
4,476
William Landschulz
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
27
40
15,227
Ian C Smith
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
27
38
10,427
Vladislav Kiselyov
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
27
36
2,688
Haoda Fu
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
26
49
3,383
Bayesian Statistics
Clinical Trials
Survival Analysis
Philip Szekeres
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
26
32
9,023
Oncology
Neuroscience
Life Sciences
Yongming Qu
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
26
41
2,471
Clinical trial design
missing data
generalized linear models
surrogate marker
Chafiq Hamdouchi
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
26
44
2,376
Mallikarjuna Rettiganti
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
25
55
2,272
Design of Clinical Trials
Statistics
Data Analysis
Modeling
Methods for Observational Studies
Carlos Mateos
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
25
44
2,273
Drug discovery
organic chemistry
continuous flow chemistry
Salvador Garcia Munoz
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
25
51
2,058
Multivariate Latent Variable Methods
Optimization
Process Modeling
Advanced Control
Jordi Benach
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
25
37
3,283
Synchrotron Beamlines
Macromolecular Crystallography
Drug Discovery and Design
Angus Macdonald
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
25
38
2,154
Immunology
Autoimmunity
Translational Science
Translational Medicine
Celia N Cruz
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
24
33
3,467
Yvonne Monique Kobayashi
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
24
25
4,590
Juan A Rincón
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
23
40
2,119
Gopuraja Dharmalingam
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
23
30
5,280
Genetics
Bioinformatics
Data Science and Drug Discovery Informatics
Jeremy Merritt
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
22
33
2,020
Jens Gerwien
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
22
31
3,438
Erik Hembre
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
22
27
1,545
Medicinal chemistry
drug discovery
organic chemistry
Jason R Manro
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
21
30
2,986
Alvaro Cortes Cabrera
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
21
33
1,275
machine learning
drug design
docking
molecular modeling
Amparo De La Pena
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
21
31
2,283
PK/PD
clinical pharmacology
asset management
Robert B Peery
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
21
27
2,501
Michael J Berna
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
21
23
2,435
Biotechnology
Biochemistry
Molecular Biology
Biologic Drug Development
Tim Luker
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
21
28
1,210
Zhenqi Shi
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
20
30
1,650
Xiaoyu Zhang
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
20
25
6,101
Materials Science and Engineering
Analytical
Formulation
Process
Automation
Paul H Berg
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
20
26
2,084
Leonard C Glass
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
20
23
5,676
Hugh Nuthall
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
20
23
1,171
Ernst R Dow
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
20
27
2,071
Alfredo Martin
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
20
24
1,396
Medicinal Chemsitry
Organic Chemistry
Computational Chemistry
Christos A Nicolaou
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
19
30
1,841
Chemoinformatics
cheminformatics
computer-aided drug design
data science
machine learning
James F Murray
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
19
24
2,662
Jeffrey G Suico
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
19
23
2,120
clinical pharmacology
cardiovascular disease
oncology
informatics
human factors
Eugene W Shek
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
19
21
2,796
Diabetes
Obesity
Metabolic Diseases
Cardiovascular and Diabetic Complications
NASH
Feng Pan
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
18
19
4,045
Neuroscience
Imaging
cell biology
pain
Kris Persaud
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
18
19
2,356
protein expression
protein engineering
cell engineering
vegfr2
Tomoko Ishizuka|Tomoko Morimoto-Ishizuka, Tomoko Morimoto
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
18
21
1,396
Nagendra K Prasad (Naag)
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
18
19
1,578
cancer biology
molecular biology
cell biology
tumor biology
immunology
Pindaro Martinez-Osuna
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
18
21
1,669
Rheumatology
Immunology
Autoimmunity
Clinical Trials
Medical Affairs
Mic Lajiness
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
18
21
1,564
Cheminformatics
Data Science
Analytics
Tomonori Oura
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
17
25
1,409
medicine
biostatistics
diabetes
machine learning
Jiangang Liu
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
17
19
4,537
Jeff S Mcdermott
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
17
19
1,138
Bram Brouwers
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
16
19
1,338
Type 2 diabetes
non-alcoholic fatty liver disease
exercise training
metabolic flexibility
mitochondrial function
Zhongkai Wang
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
16
18
1,085
Biostatistics
Clinical Trials
Data Science
Bishnu Thapa
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
16
20
967
Computational Chemistry
Molecular Dynamics Simulation
Quantum Chemistry
Structure-Based Drug
Xintian You
Eli Lilly and Company
Indianapolis, United States
Metrics
H-Index
i10 Index
Citation Counts
16
16
3,604